ValiRx plc (LON:VAL – Get Free Report) shares passed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of GBX 0.32 and traded as low as GBX 0.26. ValiRx shares last traded at GBX 0.26, with a volume of 4,788,559 shares traded.
ValiRx Trading Up 3.7%
The firm has a 50-day moving average of GBX 0.29 and a 200-day moving average of GBX 0.32. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.27 and a current ratio of 5.50. The firm has a market capitalization of £2.08 million, a P/E ratio of -0.30 and a beta of 0.59.
ValiRx Company Profile
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Featured Stories
- Five stocks we like better than ValiRx
- D-Wave Earnings Looked Weak, But Investors May Be Missing This
- Nebius Upside Expands as AI Feedback Loop Intensifies
- Insider Trades: Okta and Abbott See Buys, Micron Insiders Sell
- Plug Power Flips The Switch On Profitability
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.
-2027-municipal-bond-etf-logo-1200x675.jpg){kind=logo}
